IP Verse

Antibody Targeting Osteoclast-Related Protein Siglec-15

Patent No. EP2206727 (titled "Antibody Targeting Osteoclast-Related Protein Siglec-15") was filed by Daiichi Sankyo on Oct 8, 2008. The application was issued on Apr 1, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ALETHIA BIOTHERAPEUTICSDec 29, 2015GOODFELLOW

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2206727

DAIICHI SANKYO
Application Number
EP08838427A
Filing Date
Oct 8, 2008
Status
Opposition Rejected
Nov 3, 2017
Publication Date
Apr 1, 2015
External Links
Slate, Register , Google Patents